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Summary
 
Airway inflammation is believed to stimulate mucus production in asthmatic patients. Increased
mucus secretion is an important clinical symptom and contributes to airway obstruction in
asthma. Activated CD4 Th1 and Th2 cells have both been identified in airway biopsies of asth-
matics but their role in mucus production is not clear. Using CD4 T cells from mice transgenic
for the OVA-specific TCR, we studied the role of Th1 and Th2 cells in airway inflammation
and mucus production. Airway inflammation induced by Th2 cells was comprised of eosino-
phils and lymphocytes; features found in asthmatic patients. Additionally, there was a marked
increase in mucus production in mice that received Th2 cells and inhaled OVA, but not in
mice that received Th1 cells. However, OVA-specific Th2 cells from IL-4–deficient mice
were not recruited to the lung and did not induce mucus production. When this defect in
homing was overcome by administration of TNF-
 
a
 
, IL-4 
 
2
 
/
 
2
 
 Th2 cells induced mucus as ef-
fectively as IL-4 
 
1
 
/
 
1
 
 Th2 cells. These studies establish a role for Th2 cells in mucus produc-
tion and dissect the effector functions of IL-4 in these processes. These data suggest that IL-4 is
crucial for Th2 cell recruitment to the lung and for induction of inflammation, but has no di-
rect role in mucus production.
 
A
 
sthma is a chronic inflammatory disease of the bron-
chial airways defined by intermittent episodes of air-
way obstruction. Patients with asthma present with wheez-
ing and cough productive of mucous secretions. Mucus
hypersecretion is an important cause of airway obstruction
in asthma (1, 2). Airway biopsies show infiltration of the
mucosa and submucosa with lymphocytes and eosinophils
and hyperplasia of goblet cells and submucosal glands. In
autopsy specimens from patients who died in status asth-
maticus, obstructing plugs of mucus and cellular debris
have been identified in the small airways.
In asthma, mucus hypersecretion is believed to result, at
least in part, from inflammation, although the mechanisms
by which mucus is induced have not been detailed. Studies
have shown that the volume of expectorated sputum in
asthmatics correlates with the number of eosinophils in the
sputum (3). In addition, sputum DNA levels correlate with
mucus production (4). A variety of inflammatory mediators
have been shown to stimulate mucus secretion including
histamine, prostaglandins, leukotrienes, platelet activating
factor, and eosinophil cationic protein (5, 6). The cytokines
IL-4 and IL-5 have recently been shown to effect airway
epithelial mucus production. Transgenic mice that overex-
press IL-4 or IL-5 in the lung each showed a marked in-
crease in mucus in the airway epithelium (7, 8). It is unclear
if IL-4 and/or IL-5 act directly on the airway epithelium or
if these cytokines are some of many inflammatory media-
tors involved in mucus production.
The regulation of airway epithelial cell mucus produc-
tion by CD4 T cells has not been studied, although CD4 T
cells are thought to play a primary role in initiating the in-
flammatory cascade that leads to asthma. Activated CD4 T
cells have been identified in bronchial biopsies and bron-
choalveolar lavage fluid of asthmatic patients (9–11), and
animal models have shown that depletion of CD4 T cells
inhibits airway inflammation (12, 13). Antigen-activated CD4
T cells can differentiate into effector cells with distinct
functional properties (14–16). Th1 cells are a subset of
CD4 T cells which secrete the potent macrophage activat-
ing cytokine, IFN-
 
g
 
. CD4 Th2 cells make a different panel
of cytokines, including IL-4, IL-5, and IL-10 (17, 18). Th2
cells are potent in activating B cells to secrete antibody,
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particularly IgE (19–21). IL-5 secretion by Th2 cells also
influences eosinophil differentiation, maturation and en-
dothelial adherence (22).
Th2 cells secreting IL-4 and IL-5 have been shown to be
present and activated in the bronchial wall of asthmatic in-
dividuals (9, 23). The presence of activated Th2 cells and
eosinophils in the airways of asthmatics have been associ-
ated with more severe airway hyperresponsiveness (24, 25).
Despite considerable correlative evidence supporting a role
for Th2 cells in the pathogenesis of asthma, a cause and ef-
fect relationship has not been shown. Furthermore, IFN-
 
g
 
has been identified in bronchoalveolar lavage (BAL)
 
1
 
 fluid
and serum of asthmatic patients suggesting that Th1-like
cells may contribute to pathology in this disease (26–29).
To better understand the role of CD4 T cells in the de-
velopment of airway pathology in asthma, we developed an
in vivo system in which antigen-specific Th1 or Th2 cells
were produced, and their ability to influence airway in-
flammation and airway epithelial mucus production was in-
vestigated. From these studies we show that Th2, but not
Th1 cells, induce an inflammatory response which is strik-
ingly similar to the pathologic features observed in human
asthmatics. Th2 cells, but not Th1 cells induce mucus hy-
persecretion in the bronchial epithelium. Furthermore, us-
ing Th2 cells deficient in IL-4, we show that IL-4 is neces-
sary for Th2-induced airway inflammation. Although current
evidence suggests that IL-4 has a role in inducing mucus
production by bronchial epithelial cells, we show that Th2-
like cells can stimulate mucus production in the absence of
IL-4.
 
Materials and Methods
 
Mice.
 
DO11.10 mice, which are transgenic for the TCR rec-
ognizing OVA peptide 323-339 (pOVA
 
323-339
 
) (30), were pro-
vided to us on BALB/c background by Ken Murphy (Washing-
ton University, St. Louis, MO) and were bred in our facilities.
IL-4–deficient BALB/c mice (Jackson Laboratories, Bar Harbor,
ME) were bred in our facilities. Transfer recipients and immuni-
zations were performed on 6–12-wk-old BALB/c mice (Jackson
ImmunoResearch Labs., West Grove, PA).
 
Generation of Th1 or Th2 Cells.
 
To generate Th1 or Th2 cells
from DO11.10 mice, CD4 T cells were isolated by negative se-
lection as previously described (31) using mAbs to CD8 (clone
53-6.72, clone 2.43 [32]), Class II MHC I-A
 
d 
 
(212.A1 [33]) and
anti–Ig-coated magnetic beads (Advanced Magnetics, Inc. Cam-
bridge, MA). Syngeneic T-depleted splenocytes were used as
APC and prepared by negative selection using antibodies to CD4
(GK1.5 [34]), anti-CD8, anti-Thy1 (35) and treatment with rab-
bit complement. APCs were mitomycin-C treated. To induce
Th2 cells from nontransgenic mice, IL-4–deficient mice and
BALB/c mice were injected intraperitoneally with 100 
 
m
 
g of
OVA (Sigma Chemical Co., St. Louis, MO) in 4.5 mg of alum
(Immuject; Sigma). 4 d after immunization, spleens and local
draining lymph nodes were harvested and CD4 T cells were iso-
 
lated. All cultures were set up in flasks containing equal numbers
of CD4 T cells and APCs at a concentration of 2–4 
 
3
 
 10
 
6
 
 cells/
ml. To generate Th1 cells, cultures contained pOVA
 
323-339
 
 at 5
 
m
 
g/ml, IL-12 at 5 ng/ml (Genetics Institute, Cambridge, MA), IL-2
at 10 U/ml (Collaborative Research Inc., Waltham, MA), and anti–
IL-4 (11B11 [36]) at inhibitory concentration. To generate Th2
cells, cultures contained pOVA
 
323-339
 
 at 5 
 
m
 
g/ml for DO11.10 cells
or OVA at 50 
 
m
 
g/ml for nontransgenic CD4 T cells, IL-4 at 200
U/ml (Collaborative Research, Inc.), IL-2 at 10 U/ml, and anti–
IFN-
 
g
 
 (XMG1.2 [37]) at inhibitory concentration. Cultures were
maintained for 4 d.
 
Transfer of Cells and Aerosol Administration of OVA.
 
Cultured Th1
or Th2-like cells were harvested after 4 d, washed with PBS and
5 
 
3 
 
10
 
6
 
 cells were injected intravenously into syngeneic BALB/c
recipients. Control mice received freshly isolated CD4 T cells
from naive BALB/c mice or in some experiments no cells were
transferred. In experiments in which mice received TNF-
 
a
 
, 2 
 
m
 
g
of TNF-
 
a
 
 (R&D Systems, Minneapolis, MN) was administered
intranasally in 50 
 
m
 
l PBS to anesthetized animals at the time of
cell transfer. 1 d after transfer of cells, mice were challenged with
inhaled 1% OVA in PBS or PBS alone for 20 min daily for 7–10 d.
Mice were placed in a plastic chamber (27 
 
3
 
 20 
 
3
 
 10 cm) fitted
with an attachment to allow entry of the aerosol from an ultra-
sonic nebulizer (1–5-
 
m
 
m particles by manufacturer’s specifica-
tions, OMRON; UltraAir NE-U07, Vernon Hills, IL). A small
hole on the opposite end of the chamber ensured continuous air-
flow.
 
Lymph Node Isolation and Bronchoalveolar Lavage.
 
Lung draining
lymph nodes (peribronchial and parathymic), were isolated and
single cell suspensions prepared for FACS
 
Ò
 
. BAL was performed
by cannulation of the trachea and lavage with 1 ml of PBS.
Cytospin preparations of BAL cells were stained with Dif-Quik
(Baxter Healthcare Corp., Miami, FL) and differentials were per-
formed based on morphology and staining characteristics. Isola-
tion of lung lymphocytes was performed after BAL and perfusion
of blood from lungs. Lung tissue was passed through a wire mesh,
digested with collagenase Type IV 150 U/ml (Worthington Bio-
chemical Corp., Freehold, NJ), elastase 10 U/ml (Sigma), and
DNase 10 U/ml (Sigma) for 1 h at 37
 
8
 
C and passed again through
a wire mesh to dissociate cells. Cell preparations were subjected
to FACS
 
Ò
 
 analysis.
 
Cytokine Production by Th1 or Th2 Cells.
 
At the time of trans-
fer, an aliquot of Th1- or Th2-like cells or naive CD4 T cells
were retained for restimulation. 1 
 
3
 
 10
 
6
 
 CD4 T cells/ml and 1 
 
3
 
10
 
6
 
/ml freshly isolated BALB/c APCs were cultured with OVA
(50 
 
m
 
g/ml) or pOVA (5 
 
m
 
g/ml). Supernatants were collected at
48 h. BAL cells obtained from individual mice were restimulated
in vitro at 2 
 
3
 
 10
 
6
 
 cells/ml in the presence of pOVA (5 
 
m
 
g/ml).
FACS
 
Ò
 
 analysis was performed on BAL cells to determine the
percentage of D011.10 transgenic CD4 T cells and the amount of
cytokine per ml per 10
 
6
 
 transgenic T cells was calculated.
 
Cytokine Assays.
 
IFN-
 
g
 
, IL-4, IL-5, and IL-10 levels from cell
supernatants were determined by ELISA (Endogen, Cambridge,
MA). Assays were standardized with recombinant IFN-
 
g
 
, IL-5, IL-10
(Endogen), and IL-4 (Collaborative Research, Inc.). The lower
limit of sensitivity for each of the ELISAs was 0.6 ng/ml (IFN-
 
g
 
),
5 pg/ml (IL-4), 0.010 ng/ml (IL-5), and 200 pg/ml (IL-10).
 
FACS
 
Ò
 
 Analysis.
 
At the time of transfer, FACS
 
Ò
 
 analysis was
performed on Th1, Th2, and naive CD4 T cell preparations to
determine the purity of transferred cell populations. Cells were
stained with anti-CD4 (Quantum Red-L3T4; Sigma) and in mice
that received DO11.10 transgenic CD4 cells, the biotinylated an-
ticlonotypic antibody, KJ1-26 (38), and fluorescein isothiocyanate-
 
1
 
Abbreviations used in this paper:
 
 BAL, bronchoalveolar lavage; DPAS, dia-
stase-periodic acid-Schiff; HMI, histologic mucus index; pOVA
 
323-339
 
,
OVA peptide 323-339. 
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avidin D (Vector Laboratories, Burlingame, CA). KJ1-26 is spe-
cific for the transgenic T cell receptor in the DO11.10 mice. After
a period of inhalational exposure, PBMC, LN, lung, and BAL
cells were also analyzed by FACS
 
Ò
 
 using these antibodies.
 
Lung Histology.
 
Lungs were prepared for histology by perfus-
ing the animal via the right ventricle with 20 ml of PBS. Lungs
were then inflated with 1.0 ml of fixative instilled through a tra-
cheostomy tube. Samples for paraffin sectioning were formalin
fixed and stained with hematoxylin and eosin (H & E), Giemsa,
diastase-periodic acid-Schiff (DPAS), mucicarmine, and alcian blue.
Immunohistochemistry was performed on lungs perfused and fixed
with periodate-lysine-pyrophosphate as previously described (39).
Sections were stained with antibodies to MHC Class II, CD4,
and the transgenic TCR using KJ1-26.
 
Histological Mucus Index.
 
Formalin-fixed, paraffin embedded
lungs were sectioned in the coronal plane at 5 microns. Lungs were
sectioned to ensure that central airways were visible. After stain-
ing with DPAS, marker dots in a grid with 2-mm spacing were
placed over the entire lung section. The slide was examined at
100
 
3
 
 final magnification on an Olympus BH-2 microscope
(Olympus, Tokyo, Japan) with a rectangular 10-mm square reti-
cule grid (American Optical Corp. Buffalo, NY) inserted in one
eyepiece. Each marker dot was placed in the lower left corner of
the field, and all intersections of airway epithelium with the reti-
cle grid were counted in that field, distinguishing mucus contain-
ing or normal epithelium. Approximately 25% of the total lung
section was scored. The ratio of total number of mucus positive
intersections and the total of all intersections, which we call the
histologic mucus index (HMI), is equivalent to the linear percent
of epithelium positive for mucus (40). This index was calculated
for each mouse lung and then the mean of the HMI was calcu-
lated for each experimental group.
 
Results
 
Generation and Characterization of OVA-specific Th1 and
Th2 Cells.
 
To investigate the effects of different T cell
subsets on airway pathology, Th1 and Th2 cells were gen-
erated from CD4 T cells isolated from DO11.10 mice
which are transgenic for the TCR recognizing pOVA 
 
323-339
 
.
Using a standard procedure to polarize CD4 T cell re-
sponses (41), splenic CD4 T cells were stimulated by
pOVA
 
323-339
 
 in the presence of IL-12, IL-2, and anti–IL-4
to induce Th1-like cells or IL-4, IL-2, and anti–IFN-
 
g
 
 to
induce Th2-like cells. 99% of the resulting activated Th1
or Th2 effector cells expressed CD4 and the DO11.10
TCR, recognized by the clonotypic monoclonal antibody,
KJ1-26. An aliquot of cells from each culture was restimu-
lated in vitro in the presence of pOVA
 
323-339
 
 and APCs,
and supernatants were assayed for IFN-
 
g
 
, IL-4, IL-5 (Fig. 1
 
A
 
), and IL-10 (data not shown). The CD4 T cells stimu-
lated to differentiate into Th1 cells produced high levels of
IFN-
 
g
 
 and undetectable IL-4, IL-5, and low levels of IL-10,
while the cells stimulated to differentiate into Th2 cells se-
creted high levels of IL-4, IL-5, IL-10, and minimal IFN-
 
g
 
. Thus, we generated CD4 Th1 and Th2 effector cells re-
sponsive to OVA peptide. Naive CD4 T cells (N) freshly
isolated from BALB/c mice did not secrete cytokines in re-
sponse to OVA.
 
In Vivo Transfer and Recruitment of OVA-specific T Cells to
the Lung.
 
To determine whether Th1 or Th2 CD4 T cells
could be recruited to the lung as committed effector cells,
DO11.10 Th1 or Th2 cells were transferred intravenously
into syngeneic BALB/c mice. A control group of mice re-
ceived unprimed naive CD4 T cells. OVA was then ad-
ministered to the mice by aerosol inhalation to recruit
OVA-specific cells to the respiratory tract and to activate
the cells locally. A control group of mice received aero-
solized PBS. After 7 d of aerosol exposure, leukocytes from
peripheral blood, lung-draining lymph nodes, BAL, and
lung tissue were isolated and analyzed by FACS
 
Ò
 
 to deter-
mine the contribution to inflammation of the transferred
population of transgenic DO11.10 CD4 T cells (Table 1).
While the donor TCR transgenic cells were not detectable
in PBMC or uninvolved lymph nodes after aerosolized
OVA, the transgenic TCR was expressed on CD4 T cells
of the draining LN (8 and 13%, Th1 and Th2). Even more
notable were the cells recovered from BAL and lung which
expressed the donor transgenic TCR on a majority of CD4
T cells after aerosolized OVA administration. However,
Figure 1. Cytokine produc-
tion by Th1 or Th2-like cells be-
fore and after transfer. (A) At the
time of transfer into recipient
mice in vitro generated
DO11.10 CD4 Th1, Th2 or
freshly isolated CD4 T cells from
naive BALB/c mice (N) were
cultured with antigen presenting
cells (2 3 106 cells/ml) in the
presence of pOVA323-339. (B) Af-
ter 7 d of exposure to inhaled
OVA, BAL was performed on
individual mice that received
Th1 (Th1-OVA), Th2 (Th2-
OVA), or naive (N) CD4 T
cells. Total leukocytes recovered
from BAL were restimulated in vitro with pOVA323-339. BAL cells from mice that received naive CD4 T cells (N) and inhaled OVA contained ,3% lym-
phocytes and were insufficient for cytokine analysis. Supernatants were collected at 48 h and cytokine ELISAs were performed. Cytokines production in
BAL was adjusted for 106 DO11.10 CD4 T cells per ml as determined by FACSÒ analysis. Mean cytokine levels (6SEM) are shown (n 5 4–5 mice per
group). One experiment is shown and is representative of three experiments. 
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TCR transgenic cells were not seen in the lung, BAL, or
lung draining LN after PBS administration. Thus, in the
mice that received donor DO11.10 CD4 T cells and expo-
sure to inhaled OVA, Th1 and Th2 cells were both re-
cruited selectively to the lung and local LN with similar ef-
ficiency.
To determine if the donor cells retained the polarized
cytokine profiles they exhibited at the time of transfer,
BAL was performed on mice after 7 d of exposure to aero-
solized OVA, and recovered cells were restimulated with
OVA. As seen in Fig. 1 
 
B
 
, BAL cells from the primed mice
that received Th1 cells (Th1-OVA) produced high levels
of IFN-
 
g
 
 and minimal IL-4, IL-5, and IL-10 (data not
shown) upon restimulation, while BAL cells from OVA-
primed mice that received Th2 donor cells (Th2-OVA)
produced IL-4, IL-5, and IL-10. BAL cells from control
mice that received naive CD4 T cells and were exposed to
inhaled OVA contained too few lymphocytes for restimu-
lation.
Thus, after transfer and exposure to aerosolized OVA,
OVA-reactive CD4 Th1 or Th2 cells were recruited to the
respiratory tract and were reactivated to secrete the cyto-
kines they exhibited at the time of transfer. The transferred
cells maintained their commitment to the secretion of Th1
or Th2 cytokines in response to OVA as has been described
previously (41).
 
Airway Inflammation in Mice that Received Th1 or Th2
Cells.
 
To investigate how different effector CD4 T cells
influence inflammation in the respiratory tract, mice that
received Th1, Th2, or unprimed naive CD4 T cells were
compared. Mice that received Th1 or Th2 cells and were
exposed to aerosolized OVA had moderate inflammation
in the respiratory tract (Fig. 2, 
 
A1
 
 and 
 
B1
 
). The lungs from
both groups of mice showed inflammation in a predomi-
nantly peribronchial and perivascular pattern. Despite simi-
lar degrees of inflammation, the two groups of mice had
strikingly different inflammatory processes as determined by
lung histology and analysis of BAL cells. The inflammatory
infiltrates in the lungs of mice that received Th1 cells con-
sisted of neutrophils, small mononuclear cells and macro-
phages (Fig. 2 
 
B1
 
). Differential counts performed on cells
recovered from BAL confirmed these findings (Fig. 3). Im-
munohistochemical analysis of lung tissue showed that many
infiltrating inflammatory cells stained with an anti-CD4 an-
tibody (Fig. 4 
 
A
 
), the majority of these cells also stained with
the TCR anticlonotypic antibody, KJ1-26 (Fig. 4 
 
B
 
). MHC
Class II expression in the lungs of these mice was increased
on bronchial epithelial cells (Fig. 4 
 
C
 
) when compared to
mice that received Th2 cells (Fig. 4 D), as expected from
the effects of IFN-g on airway epithelial cells (42).
In mice that received Th2 cells, the inflammation
showed a large proportion of infiltrating eosinophils (Fig. 2
B2). By immunohistochemistry, CD4 positive cells were
seen as the other predominant cell population in the in-
flammatory infiltrate, and a majority of CD4 expressing
cells stained with the KJ1-26 antibody (data not shown).
BAL cell counts show that eosinophils and lymphocytes
were the predominant inflammatory cells present (Fig. 3).
A minority of cells in the BAL fluid were neutrophils after
7 d of exposure to inhaled OVA. When exposures were
carried out for 10 d, the percentage of neutrophils in BAL
fluid decreased to zero, while mice that received Th1 cells
and inhaled OVA had persistence of neutrophilia (data not
shown).
Mice that received Th1 or Th2 cells and were exposed
to aerosolized PBS had no lung pathology (data not shown).
Mice that received naive CD4 T cells and aerosolized OVA
had no significant lung inflammation (Fig. 2 D). Mice that
received Th1 or Th2 cells and inhaled OVA did not ex-
hibit histopathologic evidence of inflammation in other or-
gans (data not shown).
Increased Mucus Staining and Secretion in Lungs of Mice that
Received Th2 but Not Th1 Cells. Bronchial epithelial cells
in mice that received OVA-specific Th2 cells and inhaled
OVA showed hyperplasia and extensive DPAS positive
staining indicating the presence of mucin collections (Fig. 2
B3). These findings were most striking in the central air-
ways, although peripheral airways were also involved. His-
tological sections also showed increased amounts of mucus
within the airway lumena of mice that received Th2 cells
and aerosolized OVA. The material also stained positive for
mucicarmine and alcian blue (data not shown). Mice that
received Th1 cells and inhaled OVA had minimal to absent
mucus staining (Fig. 2 A3). An HMI performed on lung
sections from mice that received Th2 cells and inhaled OVA
showed that 65% of airway epithelial cells were mucinous,
Table 1. FACSÒ Staining of Mononuclear Cells from Mice that 
Received TCR Transgenic CD4 T cells
Aerosol
exposure Source of cells
Donor cells*
Th1 Th2 N
% KJ1-261 CD4
cells (range)
— In vitro primed cells 99 99 —
at time of transfer
PBS Lung-draining LN ,1 ,1 ,1
PBS BAL ‡‡ ‡
OVA PBMC ,1 ,1 ,1
OVA Inguinal, mesenteric LN  Not tested ,1 ,1
OVA Lung-draining LN 13 (8–16) 8 (4–10) ,1
OVA BAL 69 (61–77) 57 (50–60) ,1
OVA Lung 74 73 ,1
*DO11.10 TCR transgenic Th1, Th2, or naive (N) CD4 T cells were
transferred into BALB/c mice, and the mice were exposed to 7 d of
aerosolized OVA or PBS. FACSÒ analysis was performed after aerosol
exposure to PBS or OVA, as denoted. Cells were stained with anti-
CD4 and KJ1-26 antibodies. Values are the mean percent (range) for
individual Th1 or Th2 mice (3–5 mice/group). Lung lymphocytes
were isolated and pooled from three mice.
‡After transfer of CD4 Th1, Th2, or naive cells and administration of
PBS, BAL fluid contained too few CD4 T cells for these studies.1741 Cohn et al.
while mice that received Th1 cells and inhaled OVA or na-
ive CD4 T cells and inhaled OVA had ,5% of mucinous
cells in the airways (Fig. 5).
Thus, mice that received transfer of OVA-specific Th2
cells and exposure to inhaled OVA had markedly increased
mucus staining in the bronchial epithelium. Transfer of
Th1 or Th2 cells and exposure to inhaled OVA resulted in
a comparable level of inflammation, albeit comprising dif-
ferent cell populations, but only Th2 cells stimulated bron-
chial epithelial mucus production.
IL-4 Production by Donor T Cells Is Critical for Th2 Cell-
induced Lung Inflammation. Previous studies had shown
that IL-4 overexpression in the airways resulted in mucus
hypersecretion (7). To investigate the precise mechanism
by which Th2 cells induced increased mucus staining, we
began by studying the role of IL-4 in these processes.
OVA-specific Th2 cells from IL-4–deficient (IL-4 2/2)
mice or wild-type (IL-4 1/1) BALB/c mice were gener-
ated as has been described previously (41, 43). Mice were
immunized with OVA in alum, and primed CD4 T cells
were isolated and stimulated in vitro for 4 d with OVA in
the presence of IL-4 and anti–IFN-g. An aliquot of cells
from each culture was restimulated in vitro in the presence
of OVA and APCs, and supernatants were assayed for IFN-g,
Figure 2. Lung histology in
mice that received transfer of
OVA-specific Th1, Th2, or na-
ive CD4 T cells and 7 d of aero-
solized OVA. (A1, B1, C1) 5
Th1 cell recipient. (A1) Lung
showing moderate inflammation
in peribronchial and perivascular
location; H & E, 503. (B1)
Small airway showing neutrophil
and mononuclear cellular infil-
trate; H & E, 5003. (C1) Air-
ways showing no staining for
mucus; DPAS, 1003. (A2, B2,
C2) 5 Th2 cell recipient. (A2)
Lung showing moderate inflam-
mation in peribronchial and
perivascular location; H & E,
503. (B2) Small airway show-
ing infiltrate of eosinophils and
small mononuclear cells; H & E,
5003 (C2) Airways showing in-
creased purple-staining mucus
in bronchial epithelium; DPAS,
1003. (D) Mouse that received
transfer of naive BALB/c CD4 T
cells; H & E 503.1742 Induction of Airway Mucus Production By Th2 Cells
IL-4, IL-5, and IL-10 (Table 2). IL-4 2/2 OVA-specific
Th2 cells produced comparable levels of IL-5 and IL-10
when compared to IL-4 1/1 OVA-specific Th2 cells, but
IL-4 was produced only by IL-4 1/1 Th2 cells. CD4 Th2
cells were then transferred into BALB/c IL-4 1/1 recipi-
ents and the mice were exposed to inhaled OVA for 7 d.
Control mice received no transferred cells and were ex-
posed to inhaled OVA. In contrast to mice that received
IL-4 1/1 Th2 cells, IL-4 2/2 Th2 cells did not induce
significant lung inflammation or mucus production (Fig. 6).
Mice that received IL-4 2/2 Th2 cells and inhaled OVA
had a 10-fold reduction in total BAL cell recovery com-
pared to mice that received IL-4 1/1 Th2 cells. Further-
more, eosinophils and lymphocytes were strikingly reduced
in the BAL fluid. These data suggested that IL-4 2/2 Th2
cells had either died or that production of IL-4 by the do-
nor Th2 cell was necessary for its entry into the lung. Since
staining of tissue sections revealed that VCAM-1 expression
was markedly reduced in mice that received IL-4 2/2 Th2
cells and inhaled OVA (data not shown; Cohn, L., manu-
script in preparation) and since VCAM-1 expression on
lung endothelium has previously been shown to be critical
for both lymphocyte and eosinophil recruitment to the
lung (44), these experiments suggested that the transferred
IL-4 2/2 Th2 cells were not recruited to the lung because
of a defect in lymphocyte-endothelial adhesion.
IL-4 Is not Critical for Mucus Induction Once Cells Have
Been Recruited to the Lung. To test if induction of adhe-
sion molecules on the vascular endothelium would facili-
tate recruitment of OVA-specific IL-4 2/2 Th2 cells to
the lung, we transferred OVA-specific IL-4 1/1, IL-4 2/2
Th2 cells or naive CD4 T cells into mice and treated the
mice with inhaled TNF-a. TNF-a has previously been
shown to increase both VCAM-1 and E-selectin expression
on lung endothelium (45). Mice were then exposed to 7 d
of inhaled OVA. As seen in Fig. 7 B, inflammation, as indi-
cated by increased numbers of cells in the BAL, was ob-
served in the mice that received IL-4 1/1 and IL-4 2/2
Th2 cells, whereas mice that received naive CD4 T cells
Figure 3. Bronchoalveolar lavage cell recovery in mice after transfer of
cells and exposure to inhaled OVA. Differential counts were performed
on cytospins of cells recovered from BAL from individual mice. Mean
cell counts (6SEM) are shown (n 5 5 mice per group). One experiment
is shown and is representative of three experiments. Statistical significance
was determined by unpaired Student’s t test. *P ,0.0001 Th2 vs. Th1;
‡P ,0.02 Th1 vs. Th2.
Figure 4. Immunohistochem-
ical analysis of lungs from mice
that received transfer of
DO11.10 TCR transgenic cells.
Localization in the lung of CD4
and donor TCR transgenic cells
(A, B). Sequential lung sections
from mice that received Th1
cells and exposure to aerosolized
OVA were stained with (A) anti-
CD4 and (B) KJ1-26 antibodies.
KJ1-26 recognizes the DO11.10
TCR and was present on .99%
of Th1 cells at the time of trans-
fer. An airway and small vessel
are shown with surrounding in-
flammatory cells (1003). A ma-
jority of the infiltrating cells stain
positively for both CD4 and the
transgenic TCR. (C, D) MHC
Class II expression in the lung af-
ter transfer of Th1 or Th2 cells.
Lung sections from mice that re-
ceived (C) Th1 or (D) Th2 cells
and exposure to inhaled OVA
were stained with an anti–I-A
antibody (212.A1). A small
bronchiole is shown. Both mice
that received transfer of Th1 or Th2 cells and aerosolized OVA exhibited increased MHC Class II expression on cells in the inflammatory infiltrates (red-
stained cells) (2003). Mice that received transfer of Th1 cells had increased red-staining of bronchial epithelium, whereas mice that received Th2 cells
had no evidence of Class II MHC expression on bronchial epithelial cells.1743 Cohn et al.
and TNF-a had minimal inflammation. Mucus staining
was increased in the bronchial epithelium of mice that re-
ceived IL-4 1/1 or IL-4 2/2 Th2 cells and exposure to
inhaled OVA (Fig. 7 A). Mice that received transfer of na-
ive CD4 T cells, TNF-a and inhaled OVA did not show
mucus staining in the bronchial epithelium.
OVA-specific IL-4 1/1 Th2 cells and IL-4 2/2 Th2
cells both induced eosinophilic inflammation, although IL-4
1/1 Th2 cells induced a greater degree of airway eosino-
philia (Fig. 7 B). This may the result of more effective entry
into the lung of IL-4– and IL-5–producing Th2 cells or to
a greater stability of this Th2 population compared to IL-4
2/2 Th2 cells, since it is known that IL-4 is important
for persistence of Th2 cell populations early after polariza-
tion (46).
These results show clearly that donor IL-4–deficient Th2
cells can stimulate mucus production in the airway. How-
ever, to rule out a possible role of endogenous IL-4 secre-
tion in mucus production, we transferred IL-4 1/1 and
IL-4 2/2 Th2 cells into IL-4–deficient recipient mice.
Mice were exposed to TNF-a and then aerosolized OVA
for 7 d. As seen in Fig. 8, there was persistent induction of
mucus in the airway epithelium in mice that received IL-4
2/2 Th2 cells in the absence of any recipient IL-4.
Clearly, IL-4 secreted by CD4 T cells or by other cells re-
cruited in the inflammatory process is not necessary to
stimulate mucus production in the airway epithelium.
Discussion
Th2 cells, through the production of cytokines after spe-
cific antigen stimulation, have been hypothesized to initiate
a cascade of events that leads to asthma. Although less
widely acknowledged, BAL cells from asthmatic subjects
have been shown to produce Th1-like cytokines (26–29).
Our objective was to determine whether CD4 Th2 or Th1
cells in isolation could reproduce some of the inflammatory
changes associated with asthma in a direct transfer model,
and whether these inflammatory change would influence
other important pathologic processes in asthma, specifically
mucus hypersecretion. To do this we set up in vitro cul-
tures designed to generate populations of cells containing a
Figure 5. Mucus staining in
airways of mice after transfer of
Th1, Th2, or naive (N) CD4 T
cells and exposure to inhaled
OVA. An Histologic Mucus In-
dex (HMI) was performed on
lung sections stained with DPAS.
Mean HMI (6SEM) is shown (n
5 4 mice per group). One ex-
periment is shown and is repre-
sentative of three experiments.
Statistical significance was deter-
mined by unpaired Student’s t
test.  *P  ,0.0001, Th1 vs. Th2.
Figure 6. Mucus production
and airway inflammation in mice
after transfer of IL-4 1/1 or
IL-4  2/2 Th2 cells and exposure
to inhaled OVA. BALB/c mice
received transfer of OVA-specific
IL-4  1/1 or IL-4 2/2 Th2
cells and inhaled OVA. Controls
received no cells and inhaled
OVA. (A) HMI was performed
on lung sections stained with
DPAS. Mean HMI (6SEM) is
shown. (B) BAL cells recovered
from mice after exposure to 7 d
of inhaled OVA. Differential
counts were performed on
cytospins of cells recovered from
BAL of individual mice. Mean
cell counts (6SEM) are shown
(n 5 4 mice per group). One
experiment is shown and is
representative of three experiments. Statistical significance was determined by unpaired Student’s t test. *P ,0.005, IL-4 1/1 Th2 vs. IL-4 2/2 Th2. ‡P
,0.0001, IL-4 1/1 Th2 vs. IL-4 2/2 Th2.
Table 2. Cytokine Production by Transferred OVA-specific
IL-41/1 and IL-42/2 Th2 Cells
Transferred
cell population IFN-g IL-4 IL-5 IL-10
ng/ml pg/ml ng/ml pg/ml
IL-4 1/1 Th2 nd 100 0.9 960
IL-4 2/2 Th2 nd nd 2.0 440
At the time of transfer, OVA-specific CD4 Th2 cells generated from
BALB/c (IL-4 1/1) or IL-4 2/2 mice were restimulated in vitro
with OVA. Supernatants were collected at 48 h and cytokine ELISAs
were performed. One experiment is shown and is representative of
three experiments. nd, not detectable.1744 Induction of Airway Mucus Production By Th2 Cells
high frequency of antigen-specific Th1 or Th2 cells. The
populations of CD4 effector cells we generated secreted cy-
tokines in patterns that define them as Th1 or Th2. By bi-
asing the generation towards Th1 or Th2 cells, this tech-
nique limits the potential for inducing mixed Th1 and Th2
populations typically generated by systemic immunization
with antigen. Once CD4 Th1 or Th2 cells were generated,
they were transferred into recipient mice that were then
challenged with inhaled antigen.
We demonstrate that OVA-specific CD4 Th1 or Th2
cells can be recruited and activated in the respiratory tract
and their activation results in different inflammatory pa-
thology. Th2 cells activated in the respiratory tract result in
pulmonary eosinophilia and mucus hypersecretion. Mice
that received CD4 Th1 cells and inhaled OVA have com-
parable degrees of inflammation, but do not show signifi-
cant changes in mucus production or eosinophilia. The his-
tological findings in mice that received Th2 cells have a
striking resemblance to human asthmatics.
The function of CD4 Th2 cells in modulating mucus
production has not been studied previously. We show that
Th2 cells specifically stimulate mucus hypersecretion. The
striking difference in mucus induction by Th1 and Th2
cells and the previous finding that IL-4 over-expression in-
duced mucus hypersecretion (7) suggested that this was due
to IL-4. When Th2 cells from IL-4 2/2 mice were trans-
ferred into mice and exposed to inhaled antigen there was
no increase in mucus production, however, the cells were
not recruited to the lung. These studies show the critical role
of inflammation in mucus hypersecretion and confirms ob-
servations in a variety of human diseases, including asthma,
that lung inflammation is necessary for mucus production
(47). Others have investigated the role of IL-4 in lung in-
flammation using antigen immunized IL-4–deficient mice
(48). They concluded that the lack of lymphocytes and
eosinophils in the lung after antigen challenge related to an
inability to generate Th2 cells. Recent studies show that
with prolonged antigen challenge, some airway inflamma-
tion can be induced in IL-4–deficient mice (49). In these
systemically immunized IL-4–deficient mice, inflammation
may result from activation of a mixed population of Th1
and Th2 cells, since IFN-g produced by Th1 cells can acti-
vate different inflammatory pathways. Our work shows
that IL-4 is required by Th2 cells to home to the lung and
this function of IL-4 is distinct from its effects on Th2 cell
development since in our study Th2 cells were generated
in vitro. Thus, lung inflammation induced by activated
CD4 Th2 cells is dependent on their secretion of IL-4.
The precise function of IL-4 in regulating Th2 cell–
induced inflammation in the lung is not clear. It has been
Figure 7. Mucus production
and airway inflammation in mice
after transfer of cells and expo-
sure to TNF-a and inhaled
OVA. BALB/c mice received
transfer of OVA-specific IL-4
1/1, IL-4 2/2 Th2 cells or
naive CD4 T cells (N), then ex-
posure to TNF-a and 7 d of in-
haled OVA. (A) HMI was per-
formed on lung sections stained
with DPAS. Mean HMI
(6SEM) is shown. (B) BAL cells
recovered from mice. Differential
counts  were performed on
cytospins of cells recovered from
BAL of individual mice. Mean
cell counts (6SEM) are shown
(n 5 4–5 mice per group). One
experiment is shown and is rep-
resentative of three experiments.
Statistical significance was deter-
mined by unpaired Student’s t
test. *P ,0.02, IL-4 1/1 Th2
vs. IL-4 2/2 Th2.
Figure 8. Mucus production
and airway inflammation in mice
after transfer of cells to IL-4 2/2
recipient mice. IL-4 2/2 mice
received transfer of OVA-spe-
cific IL-4 1/1 or IL-4 2/2
Th2 cells and exposure to TNF-a
and 7 d of inhaled OVA. HMI
was performed on lung sections
stained with DPAS. Mean HMI
(6SEM) is shown. (n 5 3–4
mice per group). One experi-
ment is shown and is representa-
tive of two experiments.1745 Cohn et al.
shown that IL-4 upregulates VCAM-1 expression on lung
endothelial cells (45) and the interaction of VCAM-1 and
VLA-4 on lymphocytes and eosinophils is critical for transen-
dothelial migration of these cells to lung after antigen chal-
lenge in previously sensitized mice (44). In addition,
chemokines including RANTES, MIP-1a, MCP-1, and
eotaxin, have been shown to have important roles in re-
cruitment of lymphocytes and eosinophils to the lung (50,
51). The interplay of cytokines and chemokines in recruit-
ment of leukocytes to the lung after antigen challenge is
complex. Although our studies point to a reduction in
VCAM-1 expression to explain the inhibition of inflamma-
tory cell recruitment in mice that received IL-4–deficient
Th2 cells, the precise effector function of IL-4 in these pro-
cesses has not yet been detailed.
Once Th2 IL-4 2/2 cells were activated and recruited
to the lung after administration of TNF-a to the recipient
mice, we showed that mucus was still induced in the bron-
chial epithelium. Therefore, Th2 secretion of IL-4 did not
directly induce airway epithelial mucus. Furthermore, IL-4
production by non-CD4 T cells was not directly responsi-
ble for induction of mucus.
Mucus hypersecretion was recently described in trans-
genic mice that overexpress IL-4 selectively in the lung (7).
At an early age these mice had a marked peribronchial cel-
lular infiltration with eosinophils, lymphocytes and neutro-
phils. In these transgenic mice, the precise effects of IL-4
could not be separated from the effects of other inflamma-
tory cells found in the lungs. Others have shown a tempo-
ral correlation of mucus production with lung IL-4 mRNA
levels (52). Our data show that IL-4 is crucial for mucus in-
duction. IL-4 appears to function predominantly as an ef-
fector cytokine for recruitment of inflammatory cells to the
lung to sites of antigen delivery.
The factors that directly induce mucus are still not clear.
In our studies, airway eosinophilia is associated with in-
creased airway epithelial mucus collections. Other studies
suggest that eosinophils may have a role in mucus secre-
tion. Recent studies of mice that overexpress IL-5 in the
lung epithelium show increased mucus staining in the air-
ways (8). These mice also have dramatic peribronchial infil-
tration with eosinophils. Furthermore, eosinophil cationic
protein has been shown in the guinea pig to be a mucus
secretagogue (5). Hogan et al. (49) recently showed that
mice can be induced to develop some peribronchial eosi-
nophilic inflammation, along with airway epithelial cell dam-
age and mucosal edema in the absence of IL-4. When these
mice were treated with anti–IL-5, these pathological find-
ings were inhibited, suggesting an important role for IL-5
and eosinophilia in some of the pathological changes asso-
ciated with asthma. It has also been suggested that eosino-
phils, by damaging the bronchial epithelium and exposing
the bronchial wall to more chemical stimuli, increase neu-
ral-mediated mechanisms of mucus secretion (47). We are
currently studying the role of Th2 cell secretion of IL-5 in
mucus production. CD4 Th2 cells also produce other known
factors that are distinct from Th1 cells, such as IL-10 and
IL-6, that may modulate mucus production. Henderson
et al. (53) showed that leukotriene inhibition reduced mu-
cus accumulation and eosinophilia in the airways of antigen
stimulated mice. Leukotrienes are secreted predominantly
by mast cells after IgE engagement with antigen. Thus, these
findings suggest a Th2-mediated mechanism of mucus con-
trol. We measured equivalent levels of leukotrienes in the
BAL fluid of both Th1 and Th2 mice after exposure to in-
haled OVA despite the striking differences in mucus pro-
duction (data not shown). Serum OVA-specific IgE levels
were undetectable in mice that received Th2 cells and in-
haled OVA at the time mice were sacrificed, also indicating
that mast cells were not activated in our system. Thus,
these differences suggest that mucus may be induced by a
variety of inflammatory mediators. It is not clear at present
if these mediators function through a final common path-
way, perhaps the eosinophil.
In summary, these studies examine the direct effects of T
cell subsets in airway inflammation. We have shown that
Th2 cells influence some of the pathological processes that
we associate with human asthma. Despite similar degrees
and localization of lung inflammation, Th2 cells, and not
Th1 cells, induce airway epithelial mucus production. We
have further dissected the effector functions of CD4 Th2
cells using IL-4–deficient mice. Although some recent
studies suggest that IL-4 mediates the induction of mucus,
we have shown that IL-4 is critical only for the primary
phase of mucus induction, lung inflammation. Once lung
inflammation is initiated, CD4 Th2-like cells stimulate air-
way epithelial mucus production in the absence of IL-4.
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